P‐TS‐25 | Developing a Tool to Assess Red Blood Cell Clearan…

Emerging


2
Citations
0
Refs
2023
Year
Search Works
Work Details
  • DOI 10.1111/trf.362_17554
  • OpenAlex ID W4387571979
  • Type Article
  • Language EN
  • Published 01 Oct 2023
  • Volume 63 (S5)
  • Source Transfusion
  • Publisher Wiley
  • FWCI 0.29
  • Countries 1
  • Institutions 3
  • Added 13 Oct 2023
  • Updated 30 Oct 2026
MENU
0

P‐TS‐25 | Developing a Tool to Assess Red Blood Cell Clearance in Vivo Utilizing Pathogen‐Reduced RBCs

Article 2023 EN Bronze

A simple clinical method to assess clearance of transfused RBCs would help predict the physiologic activity of antibodies or drugs implicated in hemolytic reactions. Pathogen reduction of RBCs (PR-RBCs) with amustaline/glutathione is an investigational process to reduce transfusion-transmitted infections. We describe a novel tool to track PR-RBC survival in vivo by flow cytometry (FACS) using a mo…

2

Citations

0

References

8

Authors

0.29

FWCI

Citations by Year
Last 2 years
Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
8 authors
#AuthorInstitutionsORCID
1 Richard J. Benjamin Cerus (United States) (US)
2 John P. Pitman Cerus (United States) (US)
3 Katie Waldhaus Cerus (United States) (US) —
4 José A. Cancelas —
5 Nina Mufti Cerus (United States) (US) —
6 Patricia E. Zerra Emory University (US) Children's Healthcare of Atlan… (US)
7 Ross M. Fasano Emory University (US) Children's Healthcare of Atlan… (US)
8 M. Yee Emory University (US) Children's Healthcare of Atlan… (US) —

Data: OpenAlex